ClinicalTrials.Veeva

Menu

Psychosocial Screening for Neuroendocrine Tumor Patients

P

Peking University

Status

Unknown

Conditions

Neuroendocrine Tumors

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a psychosocial screening application to usual care in a cohort of neuroendocrine tumor patients. The application involves monitoring using the NCCN Distress Thermometer(DT), Hospital Anxiety and Depression Scale(HADS), Self-Perceived Burden Scale(SPBS) and Connor-Davidson Resilience Scale(CD-RISC). These assessments will be completed at baseline, 3 months, 6 months, 12 months and 24 months. Patients will have the option of filling out questionnaires more frequently if desired.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. sign written informed consent form;
  2. age ≥ 18 years;
  3. pathologically confirmed well-differentiated neuroendocrine tumors, G1-2 (Ki67≤20%);

Exclusion criteria

  1. <18 years;
  2. Neuroendocrine carcinoma;
  3. History of psychiatric or psychologic illness;
  4. History of previous cancers or cancer distress;
  5. Patients with central nervous system(CNS) disorder;
  6. Severe, uncontrolled medical condition that would affect patients' compliance;

Trial design

100 participants in 1 patient group

Neuroendocrine tumors
Description:
Patients with neuroendocrine tumors will be given access to an application that monitors distress, anxiety, depression, self-perceived burden, and resilience at regular intervals for 3 months lasting for 24 months.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems